Allison Estrada
YOU?
Author Swipe
View article: THU353 Late Onset Of Immune Checkpoint Inhibitor-Related Diabetes After 3 Years
THU353 Late Onset Of Immune Checkpoint Inhibitor-Related Diabetes After 3 Years Open
Disclosure: S. Avula: None. A. Ahmed: None. M. Salim: None. Z.J. Anderson: None. A. Kumar: None. A. Estrada: None. Background: Immune checkpoint inhibitor-induced diabetes mellitus (ICI-DM) is characterized by acute onset of dramatic hyper…
View article: FRI334 A Case Of Delayed Onset Sheehan's Syndrome With Diabetes Insipidus
FRI334 A Case Of Delayed Onset Sheehan's Syndrome With Diabetes Insipidus Open
Disclosure: S. Inkollu: None. A. Estrada: None. Introduction: Sheehan's syndrome (SS) is characterized by hypopituitarism that develops due to ischemic pituitary necrosis from severe postpartum hemorrhage. The frequency of SS has declined …
View article: MON-418 Symptomatic Pituitary Metastasis: Two Case Reports with Contrasting Clinical Presentations
MON-418 Symptomatic Pituitary Metastasis: Two Case Reports with Contrasting Clinical Presentations Open
Introduction: Pituitary metastases (PM) are a rare occurrence with a poor prognosis. The most common cancers to metastasize to the pituitary are breast and lung. Most PMs are asymptomatic, but when symptoms occur the most commonly reported…
View article: SAT-LB099 Optimal Timing of Follow Up for Cytologically Benign Thyroid Nodules
SAT-LB099 Optimal Timing of Follow Up for Cytologically Benign Thyroid Nodules Open
Background: Thyroid nodules are common, and studies show that 85-95% of thyroid nodules are benign. Current ATA guidelines recommend continued follow up of FNA benign thyroid nodules within 24 months, due to a 0-3% false negative rate. Som…